Pushing Indian agriculture to the optimal point
It would be no exaggeration to say that in an overall sense, the journey of Indian agriculture since independence has...
Business Economics
CMS releases 2023 Medicare Advantage and Part D Advance Notice
Photo: Cecilie Arcurs/Getty Images On Wednesday the Centers for Medicare and Medicaid Services released proposed payment policy changes for Medicare...
LPL Financial Welcomes Family Team, Accardi Financial Group
CHARLOTTE, N.C., Jan. 31, 2022 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that Accardi Financial Group has joined LPL...
Business schools learn to walk the ESG talk
It was not so long ago that Jaclyn Rosebrook-Collignon and her colleagues were dismissed as the “hippies on the third...
Verizon Business and Atos to power industry-leading predictive analytics 5G edge solution
New York, N.Y., and Paris, France, January 26, 2022Verizon Business and Atos today announce an industry-leading partnership to power intelligent...
Turkey’s Erdogan Fires Statistics Chief After Record Inflation
ISTANBUL—Turkish President Recep Tayyip Erdogan replaced the head of the state statistics agency weeks after it reported record inflation, which...
FTSE 100 slides again after week of market turmoil
Good morning. Britain and the EU are said to be preparing sanctions on new Russian gas projects in retaliation for...
Winding up of schemes only after majority unitholders’ nod: Sebi
In a move aimed to further safeguard the interest of mutual fund investors, Sebi has made it mandatory...
Destiny Pharma PLC unveils further positive results for c-difficile treatment as market research points to its commercial potential
NTCD-M3, which researchers are readying to phase III clinical trials, was the subject to a separate preclinical study by the...
